Cipla Limited (CIPLA.NS)

1.385,10 +38,40 (+2,85%) Ab 11:30AM IST. Markt geöffnet.

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - General
Vollzeitmitarbeiter: 32.323

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Umang Vohra B.E., M.B.A.	MD, Global CEO & Executive Director	174,9M	N/A	1971
Dr. Raju Sunil Mistry M.A., Ph.D.	President & Global Chief People Officer	N/A	N/A	1965
Mr. Pradeep Bhadauria	President & Chief Scientific Officer	N/A	N/A	N/A
Mr. Ashish Adukia	Global Chief Financial Officer	N/A	N/A	N/A
Mr. Dinesh Ramniranjan Jain	Senior VP & Head of Corporate Finance	N/A	N/A	N/A
Ms. Geena V. Malhotra	Global Chief Technology Officer	N/A	N/A	N/A
Mr. Naveen Bansal	Head of Investor Relations	N/A	N/A	N/A
Mr. Rajendra Kumar Chopra	Compliance Officer & Company Secretary	15,3M	N/A	N/A
Ms. Heena Kanal	Senior Vice-President of Corporate Communications	N/A	N/A	N/A
Mr. Anurag Mishra	Head of Cipla Foundation	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in INR.

Beschreibung

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Corporate Governance

Cipla Limiteds ISS Governance QualityScore, Stand 1. April 2024, lautet 4. Die grundlegenden Scores sind Audit: 4, Vorstand: 3, Shareholderrechte: 1, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.